Nonprofit · EIN 47-3425850
CANCER PREVENTION INITIATIVE INC
Also known as HERITX
Tax-exempt · DALLAS, TX 75201
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $778,663 | $856,539 | -$77,876 | $1,927,394 | $360,200 | $1,567,194 |
| December 31, 2024 | 990 | $1,673,681 | $703,827 | $969,854 | $2,225,249 | $580,179 | $1,645,070 |
| December 31, 2023 | 990 | $49,585 | $74,394 | -$24,809 | $821,212 | $145,996 | $675,216 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $701,483
- Program service revenue
- $0
- Investment income
- $77,180
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $725,000
- Compensation of officers, directors and key employees
- $0
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $90,000
- Accounting fees
- $12,310
- Depreciation
- $1,600
- Program services (functional)
- $731,546
- Management and general (functional)
- $28,204
- Fundraising (functional)
- $96,789
Balance sheet and other
- Total assets, start of year
- $2,225,249
- Total assets, end of year
- $1,927,394
- Total liabilities, end of year
- $360,200
- Net assets, end of year
- $1,567,194
- Publicly traded securities
- $1,855,633
- Net assets without donor restrictions
- $535,694
- Net assets with donor restrictions
- $1,031,500
- Gross receipts
- $778,663
- Employees
- 0
- Volunteers
- 5
- Year formed
- 2015
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Theodora Ross | President & Chief Scientific Officer; Trustee Trustee or director, Officer | 5 | $0 |
| Howard Janzen | Board Chair; Secretary; Trustee Trustee or director, Officer | 5 | $0 |
| Jan Livingston-Mokhtari | Trustee Trustee or director | 1 | $0 |
| Douglas Hager | Trustee, Sr. Vice President, Project Management and Operations Trustee or director | 10 | $0 |
| Joi Morris | Treasurer, Trustee Trustee or director, Officer | 6 | $0 |
| Kirk Patrick | Secretary, Trustee Trustee or director | 0.5 | $0 |
990 for the year ended December 31, 2024: 6 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Theodora Ross | President & Chief Scientific Officer Trustee or director, Officer | 5 | $0 |
| Howard Janzen | Board Chair; Chief Financial Officer Trustee or director, Officer | 5 | $0 |
| Kirk Patrick | Secretary, Trustee Trustee or director, Officer | 0.5 | $0 |
| Jan Livingston-Mokhtari | Trustee Trustee or director | 0.5 | $0 |
| Douglas Hager | Trustee, Sr. Vice President, Project Management and Operations Trustee or director | 10 | $0 |
| Joi Morris | Trustee Trustee or director | 5 | $0 |
990 for the year ended December 31, 2023: 6 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Theodora Ross | President & Chief Scientific Officer Trustee or director, Officer | 10 | $0 |
| Howard Janzen | Board Chair; Chief Financial Officer Trustee or director, Officer | 3 | $0 |
| Kirk Patrick | Secretary, Trustee Trustee or director, Officer | 0.5 | $0 |
| Jan Livingston-Mokhtari | Trustee Trustee or director | 0.5 | $0 |
| Douglas Hager | Trustee, Sr. Vice President, Project Management and Operations Trustee or director | 10 | $0 |
| Joi Morris | Trustee Trustee or director | 5 | $0 |
Address and contacts
- Address (IRS master file)
- 1722 ROUTH ST STE 770, DALLAS, TX 75201-2588
- In care of
- % JOI MORRIS ESQ
- Principal officer (990 for 2025)
- Theodora Ross, 1722 Routh Street, Suite 770, Dallas, TX 75201
- Signed the 990
- Theodora Ross, President
- Phone
- (844) 437-4891
Mission
Cancer Prevention Initiative, Inc. (CPI) is a nonprofit corporation whose mission is to accelerate the discovery and development of new medicines that prevent cancer. CPI uses its research, medical and pharmaceutical expertise to invest in first-rate science that will discover new medical methods for preventing cancer. Our strategy is to support research on prevention of inherited cancers as a path towards elimination of all cancers. CPI acts as a facilitator to ensure that good ideas can find sufficient funding to turn them into therapeutic solutions such as drugs or vaccines to prevent cancer. CPI provides financial support, guidance and expertise throughout the research and development process to help researchers use the resources (donations) for the highest possible impact.
Program accomplishments
- In 2025, Cancer Prevention Initiative (CPI) supported five active projects studying therapeutic prevention of inherited cancer. Four of the projects study BRCA1/2 mutated cancers and one project studies Lynch Syndrome. Two of the projects, one at Cleveland Clinic and one at Dana-Farber, are developing immunoprevention strategies to combat BRCA mutant breast cancer. Another immunoprevention project at MD Anderson is developing vaccines to prevent Lynch syndrome-associated colorectal cancer. The project at Harvard/Beth Israel Deaconess Medical center is identifying risk factors in the fallopian tube that gives rise to ovarian cancer in BRCA1 mutation carriers. This work would help develop tests and assays for early detection and risk assessment of ovarian cancer. At Memorial Sloan Kettering Cancer Center, CPI supports a project to prevent Loss of Heterozygosity (LoH) of BRCA genes, a major driver in cancer initiation, and thereby prevent the development of cancer.Expenses $731,546 · grants $725,000
- Education and engagement programs: As we move closer to our goal of eradicating all cancers through preventative medicines, we believe that raising awareness about inherited cancer syndromes will inspire more individuals to take proactive, life-saving preventive measures. One of the goals is to enhance the scientific reach of the organization and raise awareness on cancer prevention to a broader audience of patients, advocates and donors. Updates on scientific and medical research advances, recent clinical trials, and interviews with experts in cancer prevention are published on web-based platforms.0
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 47-3425850
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2015
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H30)
- Assets (IRS master file)
- $1,927,394
- Income (IRS master file)
- $778,663
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $778,663 | $856,539 | $1,927,394 | IRS |
| 990 | December 2024 | $1,673,681 | $703,827 | $2,225,249 | IRS |
| 990 | December 2023 | $49,585 | $74,394 | $821,212 | XML |
| 990 | December 2022 | $257,068 | $18,418 | $1,056,196 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 47-3425850).
Questions about CANCER PREVENTION INITIATIVE INC
- What is the EIN of CANCER PREVENTION INITIATIVE INC?
- The employer identification number (EIN) of CANCER PREVENTION INITIATIVE INC is 47-3425850.
- Is CANCER PREVENTION INITIATIVE INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2015.
- Are donations to CANCER PREVENTION INITIATIVE INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does CANCER PREVENTION INITIATIVE INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of CANCER PREVENTION INITIATIVE INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did CANCER PREVENTION INITIATIVE INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of CANCER PREVENTION INITIATIVE INC?
- The 990 for the year ended December 31, 2025 names Theodora Ross.
- Who are the officers and directors of CANCER PREVENTION INITIATIVE INC?
- The 990 for the year ended December 31, 2025 lists 6 people; 0 received compensation from the organization.
- How much revenue does CANCER PREVENTION INITIATIVE INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $778,663, expenses of $856,539 and total assets of $1,927,394 at year end.
Other nonprofits in DALLAS
- BAYLOR RESEARCH INSTITUTE EIN 75-1921898 · last filed 990 for 2025
- RETINA FOUNDATION OF THE SOUTHWEST EIN 51-0151514 · last filed 990 for 2025
- CHILDRENS MEDICAL CENTER RESEARCH INSTITUTE AT THE UNIVERSITY OF TEX EIN 45-3462044 · last filed 990 for 2024
- NATIONAL OVARIAN CANCER COALITION INC EIN 65-0628064 · last filed 990 for 2024
- KIDNEY CANCER ASSOCIATION EIN 36-3719712 · last filed 990 for 2025
- OSTEOSARCOMA INSTITUTE EIN 82-2921815 · last filed 990 for 2024
- DALLAS VA RESEARCH CORPORATION EIN 75-2329831 · last filed 990 for 2025
- PEDIATRIC EPILEPSY RESEARCH FOUNDATION EIN 20-1779737 · last filed 990-PF for 2024